Home » Analyst Articles – US
BOK Financial (NASDAQ:BOKF) Price Target Raised to $127.00 at Wells Fargo & Company
BOK Financial (NASDAQ:BOKF – Free Report) had its price target hoisted by Wells Fargo & Company from $115.00 to $127.00 in a report issued on Monday,Benzinga reports. They currently have an equal weight rating on the bank’s... More of this article »
Arhaus (NASDAQ:ARHS) Price Target Lowered to $9.00 at TD Cowen
Arhaus (NASDAQ:ARHS – Free Report) had its target price decreased by TD Cowen from $12.00 to $9.00 in a research report sent to investors on Monday,Benzinga reports. TD Cowen currently has a buy rating on the stock. Several other... More of this article »
Definitive Healthcare (NASDAQ:DH) Given New $1.00 Price Target at Barclays
Definitive Healthcare (NASDAQ:DH – Free Report) had its target price decreased by Barclays from $2.75 to $1.00 in a research report sent to investors on Monday morning,Benzinga reports. Barclays currently has an underweight rating... More of this article »
Diamondback Energy (NASDAQ:FANG) Price Target Raised to $230.00 at Citigroup
Diamondback Energy (NASDAQ:FANG – Free Report) had its price target upped by Citigroup from $178.00 to $230.00 in a research note published on Monday morning,Benzinga reports. They currently have a buy rating on the oil and natural... More of this article »
Expedia Group (NASDAQ:EXPE) Upgraded to Buy at Jefferies Financial Group
Jefferies Financial Group upgraded shares of Expedia Group (NASDAQ:EXPE – Free Report) from a hold rating to a buy rating in a research report sent to investors on Monday morning, Marketbeat.com reports. The brokerage currently... More of this article »
AnaptysBio (NASDAQ:ANAB) Receives “Buy” Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a research report report published on Monday morning,Benzinga reports. The firm currently has a $66.00 target price on the biotechnology... More of this article »
Datavault AI (NASDAQ:DVLT) Given New $3.00 Price Target at Maxim Group
Datavault AI (NASDAQ:DVLT – Free Report) had its price target cut by Maxim Group from $4.00 to $3.00 in a report released on Monday,Benzinga reports. They currently have a buy rating on the stock. DVLT has been the topic of several... More of this article »
AxoGen’s (AXGN) Buy Rating Reaffirmed at Canaccord Genuity Group
Canaccord Genuity Group reaffirmed their buy rating on shares of AxoGen (NASDAQ:AXGN – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. Canaccord Genuity Group currently has a $40.00 price... More of this article »
Alumis (NASDAQ:ALMS) Price Target Cut to $25.00 by Analysts at HC Wainwright
Alumis (NASDAQ:ALMS – Free Report) had its price objective trimmed by HC Wainwright from $40.00 to $25.00 in a report released on Monday,Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities... More of this article »
Guggenheim Issues Positive Forecast for Twist Bioscience (NASDAQ:TWST) Stock Price
Twist Bioscience (NASDAQ:TWST – Free Report) had its price objective upped by Guggenheim from $50.00 to $55.00 in a research note released on Monday,Benzinga reports. The brokerage currently has a buy rating on the stock. A number... More of this article »
TSS (NASDAQ:TSSI) Now Covered by Analysts at Needham & Company LLC
Needham & Company LLC initiated coverage on shares of TSS (NASDAQ:TSSI – Free Report) in a report issued on Monday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $16.00 target price on the stock. Several... More of this article »
SLR Investment (NASDAQ:SLRC) Price Target Lowered to $15.00 at Keefe, Bruyette & Woods
SLR Investment (NASDAQ:SLRC – Free Report) had its price target trimmed by Keefe, Bruyette & Woods from $16.50 to $15.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a market... More of this article »
Syndax Pharmaceuticals (NASDAQ:SNDX) Given Buy Rating at Jefferies Financial Group
Jefferies Financial Group reiterated their buy rating on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a research note released on Monday morning,Benzinga reports. Jefferies Financial Group currently has a... More of this article »
Starbucks (NASDAQ:SBUX) Coverage Initiated by Analysts at Citizens Jmp
Citizens Jmp started coverage on shares of Starbucks (NASDAQ:SBUX – Free Report) in a research report report published on Monday morning, MarketBeat Ratings reports. The firm issued a mkt underperform rating and a $84.00 price... More of this article »
Sanmina (NASDAQ:SANM) Coverage Initiated by Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. assumed coverage on shares of Sanmina (NASDAQ:SANM – Free Report) in a report issued on Monday, MarketBeat Ratings reports. The brokerage issued a neutral rating and a $145.00 price objective on the... More of this article »
Tesla (NASDAQ:TSLA) Receives Sell Rating from Glj Research
Glj Research reaffirmed their sell rating on shares of Tesla (NASDAQ:TSLA – Free Report) in a research report sent to investors on Monday morning,Benzinga reports. A number of other equities research analysts also recently issued... More of this article »
Terns Pharmaceuticals’ (TERN) Equal Weight Rating Reaffirmed at Barclays
Barclays reissued their equal weight rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a report issued on Monday morning,Benzinga reports. Barclays currently has a $53.00 target price on the stock, down... More of this article »
Veritone (NASDAQ:VERI) Receives “Buy” Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Veritone (NASDAQ:VERI – Free Report) in a research report sent to investors on Monday morning,Benzinga reports. The brokerage currently has a $9.00 price objective on the... More of this article »
Trimble (NASDAQ:TRMB) Given New $85.00 Price Target at Robert W. Baird
Trimble (NASDAQ:TRMB – Free Report) had its price target decreased by Robert W. Baird from $90.00 to $85.00 in a report published on Monday,Benzinga reports. Robert W. Baird currently has an outperform rating on the scientific... More of this article »
Veracyte (NASDAQ:VCYT) Price Target Cut to $45.00 by Analysts at Guggenheim
Veracyte (NASDAQ:VCYT – Free Report) had its price objective trimmed by Guggenheim from $50.00 to $45.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has a buy rating on the biotechnology company’s... More of this article »
SLM (NASDAQ:SLM) Upgraded by Compass Point to “Neutral” Rating
Compass Point upgraded shares of SLM (NASDAQ:SLM – Free Report) from a sell rating to a neutral rating in a research note released on Monday morning, MarketBeat.com reports. They currently have $22.00 price objective on the credit... More of this article »
United Therapeutics (NASDAQ:UTHR) Given New $660.00 Price Target at TD Cowen
United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective hoisted by TD Cowen from $575.00 to $660.00 in a research report released on Monday morning,Benzinga reports. TD Cowen currently has a buy rating on the... More of this article »
Tempus AI (NASDAQ:TEM) Price Target Cut to $60.00 by Analysts at Guggenheim
Tempus AI (NASDAQ:TEM – Free Report) had its target price cut by Guggenheim from $95.00 to $60.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have a buy rating on the stock. A number... More of this article »
Qualcomm (NASDAQ:QCOM) Now Covered by The Goldman Sachs Group
The Goldman Sachs Group initiated coverage on shares of Qualcomm (NASDAQ:QCOM – Free Report) in a report published on Monday, MarketBeat.com reports. The brokerage issued a neutral rating and a $135.00 price target on the wireless... More of this article »
Safe and Green Development (NASDAQ:RENX) Upgraded by Wall Street Zen to Sell Rating
Wall Street Zen upgraded shares of Safe and Green Development (NASDAQ:RENX – Free Report) to a sell rating in a research note published on Monday morning. Safe and Green Development Stock Up 0.6% RENX opened at $1.59 on Monday.... More of this article »
PTC Therapeutics (NASDAQ:PTCT) Receives “Hold” Rating from Jefferies Financial Group
Jefferies Financial Group reaffirmed their hold rating on shares of PTC Therapeutics (NASDAQ:PTCT – Free Report) in a research note released on Monday morning,Benzinga reports. The firm currently has a $76.00 target price on... More of this article »
PepsiCo (NASDAQ:PEP) Price Target Lowered to $169.00 at Deutsche Bank Aktiengesellschaft
PepsiCo (NASDAQ:PEP – Free Report) had its target price reduced by Deutsche Bank Aktiengesellschaft from $176.00 to $169.00 in a research report released on Monday morning,Benzinga reports. They currently have a buy rating on... More of this article »
Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Raised to $9.00 at Bank of America
Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) had its price target upped by Bank of America from $8.00 to $9.00 in a report published on Monday,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s... More of this article »
Penguin Solutions’ (PENG) “Buy” Rating Reaffirmed at Rosenblatt Securities
Rosenblatt Securities reaffirmed their buy rating on shares of Penguin Solutions (NASDAQ:PENG – Free Report) in a research report released on Monday,Benzinga reports. The firm currently has a $30.00 target price on the stock. PENG... More of this article »
Bank OZK (NASDAQ:OZK) Price Target Raised to $50.00 at Wells Fargo & Company
Bank OZK (NASDAQ:OZK – Free Report) had its target price hoisted by Wells Fargo & Company from $48.00 to $50.00 in a research report sent to investors on Monday morning,Benzinga reports. The firm currently has an equal weight... More of this article »
Newell Brands (NASDAQ:NWL) Given New $3.00 Price Target at Deutsche Bank Aktiengesellschaft
Newell Brands (NASDAQ:NWL – Free Report) had its target price decreased by Deutsche Bank Aktiengesellschaft from $5.00 to $3.00 in a report released on Monday morning,Benzinga reports. Deutsche Bank Aktiengesellschaft currently... More of this article »
Nuvalent (NASDAQ:NUVL) Now Covered by Wells Fargo & Company
Wells Fargo & Company started coverage on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a research note issued to investors on Monday, Marketbeat Ratings reports. The firm issued an overweight rating and a $116.00 price... More of this article »
OneSpaWorld (NASDAQ:OSW) Price Target Raised to $27.00 at TD Cowen
OneSpaWorld (NASDAQ:OSW – Free Report) had its target price hoisted by TD Cowen from $26.00 to $27.00 in a research report released on Monday morning,Benzinga reports. They currently have a buy rating on the stock. Other equities... More of this article »
Novanta (NASDAQ:NOVT) Rating Increased to Outperform at Robert W. Baird
Robert W. Baird upgraded shares of Novanta (NASDAQ:NOVT – Free Report) from a neutral rating to an outperform rating in a report released on Monday, Marketbeat Ratings reports. The firm currently has $144.00 price target on the... More of this article »
nCino (NASDAQ:NCNO) Price Target Lowered to $21.00 at Morgan Stanley
nCino (NASDAQ:NCNO – Free Report) had its target price decreased by Morgan Stanley from $36.00 to $21.00 in a research report report published on Monday,Benzinga reports. Morgan Stanley currently has an overweight rating on the... More of this article »
Netflix (NASDAQ:NFLX) Now Covered by Citizens Jmp
Citizens Jmp assumed coverage on shares of Netflix (NASDAQ:NFLX – Free Report) in a research report released on Monday, MarketBeat Ratings reports. The firm issued a market perform rating on the Internet television network’s... More of this article »
Satellos Bioscience (NASDAQ:MSLE) Price Target Raised to $11.00 at HC Wainwright
Satellos Bioscience (NASDAQ:MSLE – Free Report) had its price target upped by HC Wainwright from $1.20 to $11.00 in a research note released on Monday morning,Benzinga reports. HC Wainwright currently has a buy rating on the... More of this article »
Monopar Therapeutics (NASDAQ:MNPR) Given Buy Rating at Chardan Capital
Chardan Capital reaffirmed their buy rating on shares of Monopar Therapeutics (NASDAQ:MNPR – Free Report) in a research report report published on Monday,Benzinga reports. The firm currently has a $100.00 price objective on... More of this article »
MoonLake Immunotherapeutics’ (MLTX) Buy Rating Reaffirmed at BTIG Research
BTIG Research reiterated their buy rating on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in a report published on Monday morning,Benzinga reports. BTIG Research currently has a $30.00 target price on the... More of this article »
Monster Beverage (NASDAQ:MNST) Price Target Cut to $90.00 by Analysts at Deutsche Bank Aktiengesellschaft
Monster Beverage (NASDAQ:MNST – Free Report) had its target price decreased by Deutsche Bank Aktiengesellschaft from $94.00 to $90.00 in a report published on Monday morning,Benzinga reports. Deutsche Bank Aktiengesellschaft... More of this article »
Viridian Therapeutics (NASDAQ:VRDN) Given New $32.00 Price Target at Needham & Company LLC
Viridian Therapeutics (NASDAQ:VRDN – Free Report) had its target price lowered by Needham & Company LLC from $42.00 to $32.00 in a research report sent to investors on Monday,Benzinga reports. The brokerage currently has... More of this article »
ZOOZ Power’s (ZOOZ) Buy Rating Reaffirmed at Chardan Capital
Chardan Capital restated their buy rating on shares of ZOOZ Power (NASDAQ:ZOOZ – Free Report) in a report issued on Monday,Benzinga reports. They currently have a $2.00 target price on the stock. A number of other research firms... More of this article »
Waystar (NASDAQ:WAY) Coverage Initiated by Analysts at Morgan Stanley
Morgan Stanley started coverage on shares of Waystar (NASDAQ:WAY – Free Report) in a research report report published on Monday morning, MarketBeat Ratings reports. The firm issued an equal weight rating and a $28.00 price objective... More of this article »
GeneDx (NASDAQ:WGS) Price Target Cut to $100.00 by Analysts at Guggenheim
GeneDx (NASDAQ:WGS – Free Report) had its price target reduced by Guggenheim from $170.00 to $100.00 in a research report released on Monday,Benzinga reports. They currently have a buy rating on the stock. Several other equities... More of this article »
Vor Biopharma (NASDAQ:VOR) Coverage Initiated by Analysts at Jefferies Financial Group
Jefferies Financial Group began coverage on shares of Vor Biopharma (NASDAQ:VOR – Free Report) in a research note released on Monday, Marketbeat.com reports. The firm issued a buy rating and a $50.00 target price on the stock. Other... More of this article »
Verisk Analytics (NASDAQ:VRSK) Receives Outperform Rating from Royal Bank Of Canada
Royal Bank Of Canada reaffirmed their outperform rating on shares of Verisk Analytics (NASDAQ:VRSK – Free Report) in a report released on Monday morning,Benzinga reports. The brokerage currently has a $230.00 price target on... More of this article »
Verastem’s (VSTM) “Buy” Rating Reaffirmed at Jefferies Financial Group
Jefferies Financial Group reissued their buy rating on shares of Verastem (NASDAQ:VSTM – Free Report) in a report published on Monday,Benzinga reports. They currently have a $15.00 price objective on the biopharmaceutical company’s... More of this article »
Wingstop (NASDAQ:WING) Now Covered by Analysts at BNP Paribas Exane
BNP Paribas Exane began coverage on shares of Wingstop (NASDAQ:WING – Free Report) in a research note issued to investors on Monday, Marketbeat reports. The firm issued an outperform rating and a $275.00 price target on the restaurant... More of this article »